AACR 2024 - NSCLC poster

14 March 2024

VitroScan's Willemijn Vader, is proud to present our first ex vivo micro tumor testing correlation study for NSCLC patients at the AACR Annual Meeting 2024!
The highly feasible approach will further enable 1) better informed treatment decisions for lung cancer patients and 2) improve success for clinical development of novel therapies by near clinical testing.
The study is performed in collaboration with the study teams of the Catharina Ziekenhuis (Christi Steendam, Thomas van Brakel), Eurofins PAMM, Leiden University Medical Center (Egbert Smit, Laurie Steinbush), Groene Hart Ziekenhuis (Erica Geraedts), Laurentius Ziekenhuis, and supported by Eureka Network
 
Meet us to discover our newest advancements and discuss collaborative opportunities.

Find the abstract via: 6396 / 8 - Ex vivo 3D micro tumor testing to assess chemotherapy and immunotherapy responses for NSCLC patients

Download the poster